These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 30400722

  • 1. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC, Glass J, Giustino G, Hove JRT, Castaneda D, Torres J, Kumar A, Elman J, Ullman TA, Itzkowitz SH.
    Gut Liver; 2019 Jan 15; 13(1):54-61. PubMed ID: 30400722
    [Abstract] [Full Text] [Related]

  • 2. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
    Axelrad JE, Faye A, Slaughter JC, Harpaz N, Itzkowitz SH, Shah SC.
    Inflamm Bowel Dis; 2022 Jun 03; 28(6):855-861. PubMed ID: 34319381
    [Abstract] [Full Text] [Related]

  • 3. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC, Ten Hove JR, Castaneda D, Palmela C, Mooiweer E, Colombel JF, Harpaz N, Ullman TA, van Bodegraven AA, Jansen JM, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, van der Woude CJ, Oldenburg B, Itzkowitz SH, Torres J.
    Clin Gastroenterol Hepatol; 2018 Jul 03; 16(7):1106-1113.e3. PubMed ID: 29378311
    [Abstract] [Full Text] [Related]

  • 4. Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
    Zhang R, Lauwers GY, Choi WT.
    J Crohns Colitis; 2022 Dec 05; 16(12):1825-1834. PubMed ID: 35771958
    [Abstract] [Full Text] [Related]

  • 5. Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases.
    Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Liao KP, Kohane I.
    Clin Gastroenterol Hepatol; 2016 Jul 05; 14(7):973-9. PubMed ID: 26905907
    [Abstract] [Full Text] [Related]

  • 6. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
    Eluri S, Parian AM, Limketkai BN, Ha CY, Brant SR, Dudley-Brown S, Efron JE, Fang SG, Gearhart SL, Marohn MR, Meltzer SJ, Bashar S, Truta B, Montgomery EA, Lazarev MG.
    Dig Dis Sci; 2017 Dec 05; 62(12):3586-3593. PubMed ID: 28631086
    [Abstract] [Full Text] [Related]

  • 7. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF.
    Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898
    [Abstract] [Full Text] [Related]

  • 8. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
    Singh K, Al Khoury A, Kurti Z, Gonczi L, Reinglas J, Verdon C, Kohen R, Bessissow T, Afif W, Wild G, Seidman E, Bitton A, Lakatos PL.
    J Crohns Colitis; 2019 Sep 27; 13(10):1343-1350. PubMed ID: 30918959
    [Abstract] [Full Text] [Related]

  • 9. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK, Rutter MD.
    World J Gastroenterol; 2012 Aug 07; 18(29):3839-48. PubMed ID: 22876036
    [Abstract] [Full Text] [Related]

  • 10. Colonic neoplasia in young patients with inflammatory bowel disease and primary sclerosing cholangitis.
    Imam MH, Thackeray EW, Lindor KD.
    Colorectal Dis; 2013 Feb 07; 15(2):198-203. PubMed ID: 22712545
    [Abstract] [Full Text] [Related]

  • 11. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U, Kochhar G, Venkatesh PG, Bennett AE, Rizk M, Shen B, Kiran RP.
    J Crohns Colitis; 2013 Dec 07; 7(12):974-81. PubMed ID: 23523416
    [Abstract] [Full Text] [Related]

  • 12. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U, Jegadeesan R, Gutierrez NG, Venkatesh PG, Hammel JP, Shen B, Kiran RP.
    J Crohns Colitis; 2013 Dec 07; 7(12):e684-91. PubMed ID: 23916526
    [Abstract] [Full Text] [Related]

  • 13. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY, So J, Tang W, Yip TCF, Leung WK, Li M, Lo FH, Ng KM, Sze SF, Leung CM, Tsang SWC, Shan EHS, Chan KH, Lam BCY, Hui AJ, Chow WH, Chan FKL, Ng SC.
    Scand J Gastroenterol; 2020 Mar 07; 55(3):279-286. PubMed ID: 32119788
    [Abstract] [Full Text] [Related]

  • 14. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Mar 07; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 15. Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitis.
    Kaplan GG, Heitman SJ, Hilsden RJ, Urbanski S, Myers RP, Lee SS, Burak KW, Swain M, Panaccione R.
    Inflamm Bowel Dis; 2007 Nov 07; 13(11):1401-7. PubMed ID: 17600816
    [Abstract] [Full Text] [Related]

  • 16. Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Torres J, Pineton de Chambrun G, Itzkowitz S, Sachar DB, Colombel JF.
    Aliment Pharmacol Ther; 2011 Sep 07; 34(5):497-508. PubMed ID: 21692821
    [Abstract] [Full Text] [Related]

  • 17. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG, Jegadeesan R, Gutierrez NG, Sanaka MR, Navaneethan U.
    J Crohns Colitis; 2013 Dec 07; 7(12):968-73. PubMed ID: 23433613
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory bowel disease as a risk factor for colorectal cancer.
    Lukas M.
    Dig Dis; 2010 Dec 07; 28(4-5):619-624. PubMed ID: 21088413
    [Abstract] [Full Text] [Related]

  • 19. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom.
    Thomas T, Nair P, Dronfield MW, Mayberry JF.
    Eur J Gastroenterol Hepatol; 2005 Dec 07; 17(12):1317-24. PubMed ID: 16292084
    [Abstract] [Full Text] [Related]

  • 20. Risk of colorectal cancer in self-reported inflammatory bowel disease and modification of risk by statin and NSAID use.
    Samadder NJ, Mukherjee B, Huang SC, Ahn J, Rennert HS, Greenson JK, Rennert G, Gruber SB.
    Cancer; 2011 Apr 15; 117(8):1640-8. PubMed ID: 21472711
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.